Diamyd appoints Peter Zerhouni as President


News widgets and RSS feeds on


Monday, 04 July 2011
The Board of Diamyd Medical has appointed Peter Zerhouni, Acting President of Diamyd Medical AB, as President of the Company.

Peter Zerhouni has been involved in all aspects of the Company since 2006 and he is since April 2011 Acting President and CEO of the Company. He assumes his position as President and CEO of Diamyd Medical AB on July 4, 2011.


Peter Zerhouni has during the years played a key role in driving the Company’s business and clinical trials forward. He has a combined financial and biotechnology background with degrees in Biology and Economics & Business Administration from Lund University in Sweden and University of California at Berkeley in the USA.
Based on press release distributed by Cisionwire

Print this article

What do you think about this article? Would you like to leave a comment? It will be much appreciated. You can also rate this article.

  • Should be Empty:

Scandinavian Companies & Market Magazine
(C) 2010  Granscole Establishment Sweden AB. Registered in Sweden as a Media Company. Organisation Number: 556782-6572
F-Skatt (VAT) Number: SE556782657201